Phenominer Database Results (89 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Clinical Measurement Notes Record ID Study ID
SS/Jr heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. heart left ventricle end-diastolic diameter male 109 days-112 days 6 44.0 % 4.0 9.8 transthoracic echocardiography 0 0 65749 283
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. heart left ventricle end-diastolic diameter male 109 days-112 days 7 57.0 % 3.0 7.94 transthoracic echocardiography 0 0 65751 283
SS/JrSeac heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 35 days) Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. heart left ventricle end-diastolic diameter not specified 77 days 5 FS=(EDD−ESD)/EDD 46.0 % 2.91 6.5 transthoracic echocardiography 0.0 0 68575 733
SS/JrSeac heart left ventricle fractional shortening controlled sodium content diet (8 %) (for 84 days) Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. heart left ventricle end-diastolic diameter not specified 126 days 5 FS=(EDD−ESD)/EDD 23.0 % 2.59 5.8 transthoracic echocardiography 0.0 0 68578 733
SS/Jr heart left ventricle fractional shortening controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. heart left ventricle end-diastolic diameter male 77 days 40 (LVDdLVDs)/LVDd x 100 50.7 % 0.83 5.25 transthoracic echocardiography 0.0 0 68282 542
SS.LEW-(D18Rat29-D18Rat55)/Ayd heart left ventricle fractional shortening controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. heart left ventricle end-diastolic diameter male 77 days 11 (LVDdLVDs)/LVDd x 100 47.7 % 1.16 3.84 transthoracic echocardiography 0.0 0 68283 542
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening control condition (for 28 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 28 days 7 54.9 % 6.9 18.26 echocardiography 0.0 0 99634 2319
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening control condition (for 56 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 56 days 6 48.3 % 8.1 19.84 echocardiography 0.0 0 99636 2319
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening control condition (for 84 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 84 days 10 47.3 % 4.1 12.97 echocardiography 0.0 0 99638 2319
SS.ZUC-Leprfa+/+/Slc heart left ventricle fractional shortening bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. heart left ventricle end-diastolic diameter female 91 days 9 39.8 % 2.5 7.5 echocardiography 0.0 ovariectomy 42 days 101719 2622
WKY heart left ventricle fractional shortening left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. heart left ventricle end-diastolic diameter male 238 days-252 days 20 15.1 % 1.0 4.47 echocardiography 0.0 lad occlusion 196 days 100349 2460
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 252 days 6 39.2 % 5.8 14.21 echocardiography 0.0 0 99809 2319
SS.ZUC-Leprfa+/+/Slc heart left ventricle fractional shortening control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. heart left ventricle end-diastolic diameter male 91 days 8 32.62 % 1.67 4.72 echocardiography 0.0 0 101805 2641
SBH/Ygl heart left ventricle fractional shortening controlled sodium chloride content diet (8 %) (for 42 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. heart left ventricle end-diastolic diameter male 98 days 7 65.0 % 1.0 2.65 transthoracic echocardiography 0.0 0 106715 3038
SS/JrHsdMcwi heart left ventricle fractional shortening angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. heart left ventricle end-diastolic diameter male 63 days-70 days 5 57.2 % 2.7 6.04 transthoracic echocardiography 0.0 0 105828 3023
WKY heart left ventricle fractional shortening left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. heart left ventricle end-diastolic diameter male 238 days-252 days 30 15.8 % 0.7 3.83 echocardiography 0.0 lad occlusion 196 days 100350 2460
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. heart left ventricle end-diastolic diameter male 91 days 12 38.55 % 1.09 3.78 echocardiography 0.0 0 101808 2641
SS-Adora2bem2Mcwi heart left ventricle fractional shortening isoflurane (1-2 %) Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. heart left ventricle end-diastolic diameter male 147 days 10 54.3 % 1.4 4.43 transthoracic echocardiography 0.0 0 105801 3023
WKY heart left ventricle fractional shortening sham surgical control condition (for 224 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. heart left ventricle end-diastolic diameter male 266 days-280 days 5 51.5 % 1.7 3.8 echocardiography 0.0 lad occlusion sham 210 days 100303 2460
SS/JrSeac heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 84 days) Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. heart left ventricle end-diastolic diameter not specified 126 days 5 FS=(EDD−ESD)/EDD 44.0 % 2.91 6.5 transthoracic echocardiography 0.0 0 68577 733
SS.LEW-(D16Chm36-D16Mit2)/Ayd heart left ventricle fractional shortening controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. heart left ventricle end-diastolic diameter male 77 days 18 (LVDdLVDs)/LVDd x 100 44.1 % 1.38 5.87 transthoracic echocardiography 0.0 0 68285 542
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening control condition (for 168 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 168 days 5 43.4 % 1.5 3.35 echocardiography 0.0 0 99640 2319
SS/NEisSlc heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. heart left ventricle end-diastolic diameter male 126 days 8 24.8 % 1.2 3.39 transthoracic echocardiography 0.0 0 102317 2684
Crl:WI heart left ventricle fractional shortening control condition Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. heart left ventricle end-diastolic diameter male 168 days 4 43.45 % 1.78 3.56 echocardiography 0.0 0 103119 2786
GK/CskCrljCrl heart left ventricle fractional shortening control condition Devanathan S, et al., PLoS One. 2013 Oct 21;8(10):e78477. doi: 10.1371/journal.pone.0078477. eCollection 2013. heart left ventricle end-diastolic diameter male 168 days 4 38.2 % 4.45 8.89 echocardiography 0.0 0 103120 2786
SD heart left ventricle fractional shortening sham surgical control condition (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 41.0 % 2.0 4.47 echocardiography 0.0 sham ACF 2 days ledd/pw 99363 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 48.0 % 5.0 11.18 echocardiography 0.0 ACF 2 days ledd/pw 99364 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 37.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99368 2278
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 84 days 6 44.3 % 2.9 7.1 echocardiography 0.0 0 99805 2319
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening vehicle control condition Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 168 days 7 44.3 % 2.8 7.41 echocardiography 0.0 0 99806 2319
SS.ZUC-Leprfa+/+/Slc heart left ventricle fractional shortening everolimus (0.83 mg/kg/d) (for 28 days) Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. heart left ventricle end-diastolic diameter male 91 days 10 35.33 % 1.87 5.91 echocardiography 0.0 0 101806 2641
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening vehicle control condition (0.5 %) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle end-diastolic diameter male 91 days 13 47.66 % 2.43 8.76 echocardiography 0.0 0 102007 2644
SBH/Ygl heart left ventricle fractional shortening controlled sodium chloride content diet (0.65 %) (for 98 days) Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. heart left ventricle end-diastolic diameter male 98 days 7 66.0 % 1.0 2.65 transthoracic echocardiography 0.0 0 106712 3038
SS-Adora2bem2Mcwi heart left ventricle fractional shortening isoflurane (1-2 %) Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. heart left ventricle end-diastolic diameter male 49 days-56 days 7 49.0 % 2.3 6.09 transthoracic echocardiography 0.0 0 105827 3023
SD-Myh7bem1Blar+/- heart left ventricle fractional shortening control condition Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. heart left ventricle end-diastolic diameter not specified 84 days 0 84.34 % 11.12 echocardiography 0.0 0 110947 3192
SS/JrSeac heart left ventricle fractional shortening controlled sodium content diet (8 %) (for 35 days) Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. heart left ventricle end-diastolic diameter not specified 77 days 5 FS=(EDD−ESD)/EDD 57.0 % 2.64 5.9 transthoracic echocardiography 0.0 0 68576 733
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle end-diastolic diameter male 91 days 13 43.53 % 1.18 4.25 echocardiography 0.0 0 102008 2644
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening vehicle control condition Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 84 days 7 47.3 % 4.1 10.85 echocardiography 0.0 0 99804 2319
SR/NEisSlc heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. heart left ventricle end-diastolic diameter male 126 days 8 52.6 % 0.7 1.98 transthoracic echocardiography 0.0 0 102316 2684
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening vehicle control condition Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 252 days 7 41.6 % 5.6 14.82 echocardiography 0.0 0 99808 2319
SS.SR-(D3Arb14-D3Mco36)/Mco heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. heart left ventricle end-diastolic diameter male 109 days-112 days 7 54.0 % 3.0 7.94 transthoracic echocardiography 0 0 65750 283
SS.LEW-(D3Rat52-D3Chm57)/Ayd heart left ventricle fractional shortening controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. heart left ventricle end-diastolic diameter male 77 days 8 (LVDdLVDs)/LVDd x 100 48.3 % 1.82 5.15 transthoracic echocardiography 0.0 0 68288 542
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening control condition (for 252 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 252 days 5 38.8 % 2.6 5.81 echocardiography 0.0 0 99642 2319
SD heart left ventricle fractional shortening sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 7 38.0 % 2.0 5.29 echocardiography 0.0 sham ACF 28 days 99367 2278
SS.ZUC-Leprfa+/+/Slc heart left ventricle fractional shortening bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. heart left ventricle end-diastolic diameter female 91 days 12 55.2 % 1.9 6.58 echocardiography 0.0 ovariectomy 42 days 101720 2622
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. heart left ventricle end-diastolic diameter female 91 days 7 61.3 % 2.7 7.14 echocardiography 0.0 ovariectomy 42 days 101722 2622
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 34.0 % 2.0 6.32 echocardiography 0.0 ACF 105 days 99258 2278
SD-Myh7bem1Blar-/- heart left ventricle fractional shortening control condition Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. heart left ventricle end-diastolic diameter not specified 84 days 0 81.02 % 10.01 echocardiography 0.0 0 110946 3192
SS.SR-(D7Mco19-D7Mco7)/Jr heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. heart left ventricle end-diastolic diameter male 109 days-112 days 4 40.0 % 3.0 6.0 transthoracic echocardiography 0 0 65752 283
SS.LEW-(D18Chm41-D18Rat92)/Ayd heart left ventricle fractional shortening controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. heart left ventricle end-diastolic diameter male 77 days 8 (LVDdLVDs)/LVDd x 100 49.1 % 1.13 3.19 transthoracic echocardiography 0.0 0 68284 542
SR heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. heart left ventricle end-diastolic diameter male 126 days 6 33.0 % 1.63 4.0 transthoracic echocardiography 0.0 0 103319 2803
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening controlled sodium content diet (for 21 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 98 days 4 47.0 % 1.41 2.82 echocardiography 0.0 0 99725 2319
SR heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. heart left ventricle end-diastolic diameter male 84 days 6 32.0 % 2.45 6.0 transthoracic echocardiography 0.0 0 103317 2803
SS heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. heart left ventricle end-diastolic diameter male 126 days 6 26.0 % 1.22 3.0 transthoracic echocardiography 0.0 0 103318 2803
SS-Nppbem2Mcwi+/+ heart left ventricle fractional shortening control condition (for 56 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 56 days 5 48.0 % 3.9 8.72 echocardiography 0.0 0 99635 2319
SS-Nppbem2Mcwi+/+ heart left ventricle fractional shortening control condition (for 168 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 168 days 5 46.8 % 1.2 2.68 echocardiography 0.0 0 99639 2319
SS/NEisSlc heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. heart left ventricle end-diastolic diameter male 126 days 8 44.3 % 1.0 2.83 transthoracic echocardiography 0.0 0 102318 2684
SS-Nppbem2Mcwi+/+ heart left ventricle fractional shortening controlled sodium content diet (for 21 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 98 days 4 41.7 % 2.62 5.24 echocardiography 0.0 0 99724 2319
SS-Nppbem2Mcwi+/+ heart left ventricle fractional shortening control condition (for 252 days) Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. heart left ventricle end-diastolic diameter female 252 days 4 49.5 % 2.2 4.4 echocardiography 0.0 0 101655 2621
SD heart left ventricle fractional shortening sham surgical control condition (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 38.0 % 4.0 11.31 echocardiography 0.0 sham ACF 28 days 99255 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 38.0 % 2.0 5.66 echocardiography 0.0 ACF 28 days 99256 2278
SD heart left ventricle fractional shortening sham surgical control condition (for 105 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 175 days 10 40.0 % 1.0 3.16 echocardiography 0.0 sham ACF 105 days 99257 2278
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. heart left ventricle end-diastolic diameter female 91 days 8 47.7 % 1.9 5.37 echocardiography 0.0 ovariectomy 42 days 101721 2622
SS/JrHsdMcwi heart left ventricle fractional shortening isoflurane (1-2 %) Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. heart left ventricle end-diastolic diameter male 147 days 10 51.0 % 1.2 3.79 transthoracic echocardiography 0.0 0 105800 3023
SS-Adora2bem2Mcwi heart left ventricle fractional shortening angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. heart left ventricle end-diastolic diameter male 77 days-84 days 7 48.2 % 3.5 9.26 transthoracic echocardiography 0.0 0 105831 3023
SD-Myh7bem1Blar+/+ heart left ventricle fractional shortening control condition Chen P, etal., Sci China Life Sci. 2020 Sep;63(9):1347-1362. doi: 10.1007/s11427-019-1627-y. Epub 2020 Mar 17. heart left ventricle end-diastolic diameter not specified 84 days 0 72.52 % 16.33 echocardiography 0.0 0 SD-Myh7bem1Blar+/+ (RS:0005005) 110945 3192
SS.LEW-(D10Got112-Igfbp4)/Ayd heart left ventricle fractional shortening controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. heart left ventricle end-diastolic diameter male 77 days 5 (LVDdLVDs)/LVDd x 100 49.9 % 1.77 3.96 transthoracic echocardiography 0.0 0 68287 542
WKY heart left ventricle fractional shortening sham surgical control condition (for 196 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. heart left ventricle end-diastolic diameter male 238 days-252 days 12 41.1 % 3.0 10.39 echocardiography 0.0 lad occlusion sham 196 days 100348 2460
SS-Nppbem2Mcwi+/+ heart left ventricle fractional shortening control condition (for 28 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 28 days 5 46.0 % 8.4 18.78 echocardiography 0.0 0 99633 2319
SS.LEW-(D16Rat112-D16Chm60)/Ayd heart left ventricle fractional shortening controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. heart left ventricle end-diastolic diameter male 77 days 14 (LVDdLVDs)/LVDd x 100 50.0 % 1.51 5.66 transthoracic echocardiography 0.0 0 68286 542
SS heart left ventricle fractional shortening controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. heart left ventricle end-diastolic diameter male 84 days 7 32.0 % 1.89 5.0 transthoracic echocardiography 0.0 0 103316 2803
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening control condition (for 252 days) Holditch SJ, et al., Sci Rep. 2016 May 10;6:25623. doi: 10.1038/srep25623. heart left ventricle end-diastolic diameter female 252 days 5 47.4 % 2.4 5.37 echocardiography 0.0 0 101656 2621
SS-Nppbem2Mcwi+/+ heart left ventricle fractional shortening control condition (for 84 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 84 days 6 47.0 % 2.1 5.14 echocardiography 0.0 0 99637 2319
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 50.0 % 3.0 6.71 echocardiography 0.0 ACF 2 days 99366 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 39.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99369 2278
SD heart left ventricle fractional shortening artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 98 days 8 43.0 % 1.0 2.83 echocardiography 0.0 ACF 28 days 99370 2278
SS-Nppbem2Mcwi-/- heart left ventricle fractional shortening gene transfer of the rat natriuretic peptide B gene using an adenovirus vector (100000000000 PFU) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 168 days 6 46.0 % 8.3 20.33 echocardiography 0.0 0 99807 2319
WKY heart left ventricle fractional shortening left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. heart left ventricle end-diastolic diameter male 266 days-280 days 16 16.8 % 1.6 6.4 echocardiography 0.0 lad occlusion 210 days 100304 2460
WKY heart left ventricle fractional shortening left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. heart left ventricle end-diastolic diameter male 266 days-280 days 32 18.0 % 1.5 8.49 echocardiography 0.0 lad occlusion 210 days 100305 2460
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle end-diastolic diameter male 91 days 13 44.28 % 1.6 5.77 echocardiography 0.0 0 102009 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening control condition Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. heart left ventricle end-diastolic diameter male 91 days 7 44.43 % 1.71 4.52 echocardiography 0.0 0 101807 2641
SBH/Ygl heart left ventricle fractional shortening controlled sodium chloride content diet (8 %) (for 42 days) Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. heart left ventricle end-diastolic diameter male 98 days 7 64.0 % 2.0 5.29 transthoracic echocardiography 0.0 0 106713 3038
SBH/Ygl heart left ventricle fractional shortening controlled sodium chloride content diet (0.65 %) (for 98 days) then streptozotocin (60 mg/kg) then insulin (10 ul) (for 42 days) Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. heart left ventricle end-diastolic diameter male 98 days 7 61.0 % 4.0 10.58 transthoracic echocardiography 0.0 0 106714 3038
SS/JrHsdMcwi heart left ventricle fractional shortening isoflurane (1-2 %) Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. heart left ventricle end-diastolic diameter male 49 days-56 days 5 48.0 % 1.2 2.68 transthoracic echocardiography 0.0 0 105826 3023
SS-Adora2bem2Mcwi heart left ventricle fractional shortening angiotensin II (200 ng/kg/min) (for 14 days) then isoflurane (1-2 %) Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. heart left ventricle end-diastolic diameter male 63 days-70 days 7 51.2 % 3.3 8.73 transthoracic echocardiography 0.0 0 105829 3023
SS/JrHsdMcwi heart left ventricle fractional shortening angiotensin II (200 ng/kg/min) (for 28 days) then isoflurane (1-2 %) Nayak S, et al., Purinergic Signal. 2015 Dec;11(4):519-31. doi: 10.1007/s11302-015-9470-7. Epub 2015 Sep 18. heart left ventricle end-diastolic diameter male 77 days-84 days 5 51.9 % 3.7 8.27 transthoracic echocardiography 0.0 0 105830 3023
LEW heart left ventricle fractional shortening controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. heart left ventricle end-diastolic diameter male 77 days 14 (LVDdLVDs)/LVDd x 100 48.6 % 1.21 4.54 transthoracic echocardiography 0.0 0 heart left ventricle anterior wall thickness 68281 542
SD heart left ventricle fractional shortening sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. heart left ventricle end-diastolic diameter male 72 days 5 43.0 % 2.0 4.47 echocardiography 0.0 sham ACF 2 days 99365 2278
SS-Nppbem2Mcwi+/+ heart left ventricle fractional shortening control condition (for 252 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. heart left ventricle end-diastolic diameter male 252 days 6 39.0 % 2.2 5.39 echocardiography 0.0 0 99641 2319